Skip to main navigation
Gossamer Bio logo
  • About
    • Overview
    • Team
    • Collaboration
    • Contact
  • Seralutinib
    • About Seralutinib
    • PAH
    • PH-ILD
    • Posters & Presentations
  • Patients
    • Overview
    • Expanded Access
  • Investors
    • Overview
    • News
    • Events & Presentations
      • Events
      • Presentations
    • Filings
    • Governance
      • Overview
      • Committee Composition
      • Management
      • Board of Directors
    • Stock
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Info
      • FAQs
      • Contact IR
      • Email Alerts
  • Careers & Culture
    • Who We Are
    • Open Positions

Investors

Event Details

  • Overview
  • News
  • Events and Presentations
    • Events
    • Presentations
  • Filings
  • Governance
    • Overview
    • Committee Composition
    • Management
    • Board of Directors
  • Stock
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Info
    • FAQs
    • Contact IR
    • Email Alerts

Gossamer Bio PROSERA Phase 3 Topline Results

Feb 23, 2026 8:30 AM EST

Listen to webcast

Supporting Materials

View Presentation 2.7 MB
Gossamer Bio logo

USA
3115 Merryfield Row
Suite 120
San Diego, CA 92121

Ireland
77 Sir John Rogerson’s Quay, Block C
Grand Canal Docklands
Dublin 2, D02 VK60
 

Follow Us

© Gossamer Bio | 2026 |

Privacy Statement
Gossamer Bio logo
  • About
    • Overview
    • Team
    • Collaboration
    • Contact
  • Seralutinib
    • About Seralutinib
    • PAH
    • PH-ILD
    • Posters & Presentations
  • Patients
    • Overview
    • Expanded Access
  • Investors
    • Overview
    • News
    • Events & Presentations
      • Events
      • Presentations
    • Filings
    • Governance
      • Overview
      • Committee Composition
      • Management
      • Board of Directors
    • Stock
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Info
      • FAQs
      • Contact IR
      • Email Alerts
  • Careers & Culture
    • Who We Are
    • Open Positions